Analystreport

IGM Biosciences, Inc. (NASDAQ: IGMS) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.

IGM Biosciences, Inc.  (IGMS) 
Last igm biosciences, inc. earnings: 3/26 04:05 pm Check Earnings Report